文献速递新生儿儿童神经与发育行为

极早产儿肠外脂肪乳剂量与胆红素神经毒性:析因随机试验

Parenteral Lipid Dose and Bilirubin Neurotoxicity in Extremely Preterm Infants: A Factorial Randomized Trial.
PubMed 文献 · J Pediatr · 2026-07-04

该单中心贝叶斯随机试验纳入134例出生体重≤750g或胎龄<27周的极早产儿,比较最大剂量1.5 vs 3.0 g/kg/day大豆油脂肪乳至第14天。较低剂量未降低脑干听觉诱发电位V波潜伏期,但较高剂量组游离胆红素≥30和≥40 nM更常见,提示需多中心安全性试验。

要点

  • 较低最大脂肪乳剂量未降低V波潜伏期。
  • 较高剂量组游离胆红素≥30和≥40 nM更常见。
  • 两组临床结局与生长可比。

核心结论

  • 较低最大脂肪乳剂量未降低脑干听觉诱发电位V波潜伏期。
  • 较高剂量组游离胆红素升高更常见,提示需多中心安全性试验。

研究设计与样本

  • 单中心贝叶斯随机试验,2021年1月至2024年1月在IV级新生儿重症监护病房进行。
  • 纳入出生胎龄<27周或出生体重≤750 g的极早产儿,按光疗方案分层,随机至1.5 vs 3.0 g/kg/day最大大豆油脂肪乳剂量至第14天。
  • 143例合格婴儿中134例入组(低剂量组67例,高剂量组65例)。

主要发现

  • 平均每日脂肪乳给药量低剂量组为1.1 [0.3] g/kg/day,高剂量组为1.96 [0.58] g/kg/day。
  • 两组游离胆红素水平相似,但≥30和≥40 nM值在高剂量组更常见(14.5% vs 28.6%和6.5% vs 16.1%),即使在低总血清胆红素水平(3-8 mg/dL)时。
  • 校正后V波潜伏期两组无差异(7.36 ms [0.53] vs 7.22 ms [0.57],aMD:-0.14 [95% CrI -0.34, 0.06]),与光疗剂量无交互作用。
  • 临床结局和生长两组可比。

关键数值与推荐

  • 最大大豆油脂肪乳剂量:1.5 vs 3.0 g/kg/day,至第14天。
  • 游离胆红素≥30 nM发生率:低剂量组14.5%,高剂量组28.6%。
  • 游离胆红素≥40 nM发生率:低剂量组6.5%,高剂量组16.1%。
  • 校正后V波潜伏期aMD:-0.14 ms(95% CrI -0.34, 0.06)。

临床怎么用

  • 极早产儿使用较高最大剂量大豆油脂肪乳时需关注游离胆红素升高风险。
  • 较低最大脂肪乳剂量未显示降低胆红素神经毒性指标V波潜伏期。

局限性

  • 单中心研究,样本量134例。
  • 原文未报告其他局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess whether a lower maximum dose of soybean oil lipid emulsion reduces bilirubin neurotoxicity measured by brainstem auditory evoked response wave V latency. STUDY DESIGN: Single-center Bayesian randomized trial (January 2021-January 2024) in a level IV neonatal intensive care unit. Infants born at <27 weeks or ≤750 g were stratified by phototherapy regimen, randomized to 1.5 vs 3.0 g/kg/day maximum soybean oil lipid emulsion (Intralipid) doses through day 14. RESULTS: Of 143 eligible infants, 134 were enrolled (67 lower dose, 65 higher dose). Mean [SD] daily lipid administration was 1.1 [0.3] vs 1.96 [0.58] g/kg/day. Unbound bilirubin levels were similar between groups although values ≥ 30 and ≥ 40 nM occurred more often in the higher dose group (14.5% vs 28.6% and 6.5% vs 16.1%), even at low total serum bilirubin levels (3-8 mg/dL). Adjusted wave V latency did not differ between groups (7.36 ms [0.53] vs 7.22 ms [0.57], aMD: -0.14 [95% CrI -0.34, 0.06]), with no interaction with phototherapy dose. Clinical outcomes and growth were comparable. CONCLUSIONS: The lower maximum lipid dose did not reduce brainstem auditory evoked response wave V latency. Elevated unbound bilirubin levels occurred at the higher dose, suggesting the need for a multicenter safety trial in extremely preterm infants. TRIAL REGISTRATION: ClinicalTrials.gov https://clinicaltrials.gov/study/NCT04584983.

来源:J Pediatr,查看原文。版权归原作者所有。

引用

  1. Holzapfel LF, Tyson JE, Shapiro SM, et al. Parenteral Lipid Dose and Bilirubin Neurotoxicity in Extremely Preterm Infants: A Factorial Randomized Trial. J Pediatr. 2026. PMID: 42401326. doi:10.1016/j.jpeds.2026.115225

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。